Impact of Combined High-Frequency Repetitive Transcranial Magnetic Stimulation and Acupuncture on Central Pain and Mood Disorders - Top-Institutions - MDSpire

Impact of Combined High-Frequency Repetitive Transcranial Magnetic Stimulation and Acupuncture on Central Pain and Mood Disorders

  • By

  • Xiangyue Wu

  • Binqing Li

  • Ting Xiang

  • Xiaolu Fan

  • April 27, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Pain Medicine
    • Neurorehabilitation
    • Integrative Medicine

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Pain Research
    • Rehabilitation Medicine
    • Complementary and Alternative Medicine

  • #3

    Peking University Third Hospital
    Peking University Third Hospital

    Beijing, China

    Key Differentiators

    • Neurology
    • Traditional Chinese Medicine
    • Rehabilitation
    • Pain Management

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Pain Medicine
    • Neuropsychiatry
    • Integrative Medicine

  • #5

    The Cleveland Clinic
    The Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Pain Management
    • Rehabilitation Medicine
    • Integrative Medicine

Original Source(s)

Impact of Combined High-Frequency Repetitive Transcranial Magnetic Stimulation and Acupuncture on Central Pain and Mood Disorders

  • by Xiangyue Wu, Binqing Li, Ting Xiang, Xiaolu Fan

  • April 27, 2026

Related Content

The Aging Spine: Why Earlier Recognition and Individualized Care Matter More Than Ever

With an aging population, spine disorders are becoming increasingly common. Age-related spinal degeneration is nearly universal, but not all patients experience symptoms—and not all degeneration progresses the same way. 

  • by

  • May 27, 2026

  • 5 min
Homocysteine and cognitive function in depression: a systematic review and meta-analysis

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.